Stock Events

Stock Events

Galectin Therapeutics (GALT) Q4 2025 Earnings

14NovConfirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-0.2

-0.17

-0.14

-0.11

Details

Expected EPS

-0.11

Actual EPS

-0.13

Surprise EPS

-0.02

Surprise Percent

+18.18%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.13 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.